GigaGen Inc Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

GigaGen is a San Carlos, California-based biotechnology research company and subsidiary of Grifols. It focuses on antibody therapies for immune deficiencies, infectious diseases, and cancers that resist checkpoint inhibition, using single-cell technologies to capture and reconstruct diverse immune repertoires into functional antibody libraries. Its lead oncology asset, GIGA-564, is an anti-CTLA-4 monoclonal antibody that has shown enhanced anti-tumor activity in preclinical models through a unique mechanism, and the firm continues to pursue discovery of recombinant polyclonal and monoclonal antibodies for serious diseases.

Within the biotechnology research sector, the company serves researchers and biopharmaceutical developers seeking novel antibody therapies across immune deficiencies, infectious diseases, and oncology. A notable collaboration includes a 2023 partnership with the National Cancer Institute to advance GIGA-564.

Get verified GigaGen Inc emails free

Company overview Employee directory